UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 242

of 'Systemic chemotherapy for metastatic colorectal cancer: Completed clinical trials'

242
 
 
Segal NH, Reidy-Lagunes D, Capanu M, et al. Phase II study of bevacizumab in combination with cetuximab plus irinotecan in irinotecan-refractory colorectal cancer patients who have progressed on a bavacizumab containing regimen (the BOND 2.5 study) (Abstract # 4087). J Clin Oncol 2009; 27:189s.
 
no abstract available